|
|
Volumn 39, Issue 3, 1997, Pages 533-535
|
|
Stage III nonsmall cell lung cancer: Still a challenge for the radiation oncologist
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
GEMCITABINE;
TAXANE DERIVATIVE;
TIRAPAZAMINE;
VINBLASTINE;
BRAIN METASTASIS;
CANCER CONTROL;
CANCER STAGING;
CANCER SURVIVAL;
COST BENEFIT ANALYSIS;
HUMAN;
LUNG NON SMALL CELL CANCER;
MULTIMODALITY CANCER THERAPY;
NOTE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION DOSE FRACTIONATION;
RADIOSENSITIZATION;
|
|
EID: 0030920393
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(97)00363-5 Document Type: Editorial |
|
Times cited : (2)
|
|
References (7)
|
